Precision Optics Inc (POCI) Gross Profit Margin starting from the fourth quarter 2026 to fourth quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Precision Optics Corporation Inc   (NASDAQ: POCI)


Precision Optics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



POCI Gross Profit Margin (Jun 30 2026)
Q4
(Mar 31 2026)
Q3
(Dec 31 2025)
Q2
(Sep 30 2025)
Q1
(Jun 30 2025)
Q4
Y / Y Revenue Change 41.95 %
Seq. Revenue Change 0.76 %
Revenue In Millions $8.77
Gross Profit Margin 25.34 %
Gross Profit Margin Total Ranking # 2770
Gross Profit In Millions $2.22
Y / Y Gross Profit Change 178.24 %
Seq. Gross Profit Change 8.13 %


Commenting fourth quarter 2026 Gross Profit Margin
Precision Optics Corporation Inc Gross Profit grew by 8.13 % in Q4 sequentially to 2 millions, while Revenue increased by 0.76 %, this led to improvement in the company's Gross Profit Margin to 25.34 %, Gross Profit Margin remained below Precision Optics Corporation Inc average.


Observing fourth quarter 2026 results within Medical Equipment & Supplies industry 159 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2770, from total ranking in the previous quarter at 3702.
Learn about Gross Margin
POCI's Gross Profit Margin fourth quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 160
Healthcare Sector # 407
Overall # 2746

Gross Profit Margin Statistics
High Average Low
46.29 % 27.51 % 2.78 %
(Dec 31 2022)   (Dec 31 2025)




Other Gross Profit Margin Profitability Ratios
POCI's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
POCI's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for POCI's Competitors
Gross Profit Margin Profit Margin for Precision Optics Inc 's Suppliers
Gross Profit Margin Profit Margin for POCI's Customers

You may also want to know
POCI's Annual Growth Rates POCI's Profitability Ratios POCI's Asset Turnover Ratio POCI's Dividend Growth
POCI's Roe POCI's Valuation Ratios POCI's Financial Strength Ratios POCI's Gross Profit Growth
POCI's Roa POCI's Inventory Turnover Ratio POCI's Growth Rates POCI's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Qhslab Inc   69.59 %$ 0.590  Millions$ 0.847  Millions
Globus Medical Inc   69.42 %$ 548.173  Millions$ 789.612  Millions
Bioventus Inc   68.97 %$ 105.666  Millions$ 153.208  Millions
Mimedx Group Inc   68.96 %$ 44.381  Millions$ 64.362  Millions
Skinhealth Systems Inc   68.42 %$ 49.338  Millions$ 72.113  Millions
Genedx Holdings Corp   68.37 %$ 78.238  Millions$ 114.440  Millions
Stryker Corp  68.27 %$ 4,498.000  Millions$ 6,589.000  Millions
Penumbra Inc  67.93 %$ 264.944  Millions$ 390.046  Millions
Milestone Scientific Inc   67.23 %$ 1.910  Millions$ 2.841  Millions
Nephros Inc   66.91 %$ 4.026  Millions$ 6.017  Millions
The Cooper Companies Inc   66.77 %$ 711.900  Millions$ 1,066.200  Millions
Petvivo Holdings Inc   66.15 %$ 0.223  Millions$ 0.338  Millions
Procept Biorobotics Corporation  66.01 %$ 62.379  Millions$ 94.498  Millions
Anika Therapeutics Inc   65.15 %$ 21.244  Millions$ 32.610  Millions
Koru Medical Systems Inc   65.14 %$ 7.846  Millions$ 12.045  Millions
Medtronic Plc  64.99 %$ 6,340.000  Millions$ 9,756.000  Millions
Biolife Solutions Inc   64.24 %$ 18.287  Millions$ 28.466  Millions
Safe Pro Group Inc   64.02 %$ 0.853  Millions$ 1.332  Millions
Apyx Medical Corp  63.89 %$ 8.870  Millions$ 13.884  Millions
Heartsciences Inc   63.81 %$ 0.001  Millions$ 0.002  Millions
Tenon Medical Inc   63.64 %$ 0.814  Millions$ 1.279  Millions
Dexcom Inc   63.44 %$ 830.000  Millions$ 1,308.400  Millions
Interpace Biosciences Inc   61.91 %$ 5.653  Millions$ 9.131  Millions
Clearpoint Neuro Inc   61.67 %$ 6.710  Millions$ 10.880  Millions
Dariohealth Corp   61.66 %$ 3.192  Millions$ 5.177  Millions
Enovis Corp  61.64 %$ 359.249  Millions$ 582.782  Millions
Sintx Technologies Inc   61.50 %$ 0.278  Millions$ 0.452  Millions
Haemonetics Corporation  59.76 %$ 202.803  Millions$ 339.380  Millions
Transmedics Group Inc   59.59 %$ 113.198  Millions$ 189.948  Millions
Lensar Inc   59.27 %$ 9.776  Millions$ 16.495  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.